Facilitated By

San Antonio Medical Foundation

News

  • Plus Therapeutics Announces First Patient Dosed in ReSPECT-GBM Phase 2b Trial of ... - BioSpace

    ... Program at The University of Texas Health Science Center at San Antonio and principal investigator of the ReSPECT-GBM clinical trial.

  • Rhode Island governor to propose tax relief in budget plan - MySA

    San Antonio airport TSA discovers anti-tank weapon in luggage ... McKee wants to make Rhode Island a hub for bioscience activity, a priority he ...

  • Playfully known as 'No Such Agency,' NSA looking to expand staffing in San Antonio | TPR

    The National Security Agency has more than 3,000 workers at an intelligence gathering site in San Antonio. Not many people know that because the ...

  • Oncolytics Biotech Inc. (ONCY): Does this stock hold the most enticing factor today?

    ... Activity of Pelareorep-Paclitaxel Combination Therapy in HR+/HER2- Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium.

  • Venn Negotiation CEO, Christine McKay, to Keynote The Grow Retreat 2023 in San Antonio

    Venn Negotiation CEO, Christine McKay, to Keynote The Grow Retreat 2023 in San Antonio. by PRNewswire. January 17, 2023 10:04 AM | 3 min read.